Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, announces it has entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG for an estimated cash payment on closing of approximately €760 million, less certain adjustments as provided in the purchase agreement including certain working capital not transferring and other customary adjustments. The acquired business will expand the Teleflex Interventional portfolio to include a broad suite of vascular intervention devices such as drug-coated balloons, drug-eluting stents, covered stents, balloon and self-expanding bare metal stents, and balloon catheters.
Read the full article: Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business //
Source: https://www.globenewswire.com/news-release/2025/02/27/3033652/0/en/Teleflex-to-Acquire-BIOTRONIK-s-Vascular-Intervention-Business.html
